Related references
Note: Only part of the references are listed.Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
J. W. Steele et al.
MOLECULAR PSYCHIATRY (2013)
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
J. W. Steele et al.
MOLECULAR PSYCHIATRY (2013)
The Age-related Gliosis and Accompanying Deficit in Spatial Learning are Unaffected by Dimebon
Thelma R. Cowley et al.
NEUROCHEMICAL RESEARCH (2013)
Dimebon Reduces the Levels of Aggregated Amyloidogenic Protein Forms in Detergent-Insoluble Fractions
A. A. Ustyugov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion
Werner J. Geldenhuys et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice
Sergey O. Bachurin et al.
NEUROTOXICITY RESEARCH (2012)
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis
Rachel Tesla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease
Hector De Jesus-Cortes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys
Scott J. Webster et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
Jun Wang et al.
MOLECULAR NEURODEGENERATION (2011)
APOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk
Onofre Combarros et al.
NEUROBIOLOGY OF AGING (2011)
Dimebon Does Not Ameliorate Pathological Changes Caused by Expression of Truncated (1-120) Human Alpha-Synuclein in Dopaminergic Neurons of Transgenic Mice
Tatyana A. Shelkovnikova et al.
NEURODEGENERATIVE DISEASES (2011)
Dimebon Inhibits Calcium-Induced Swelling of Rat Brain Mitochondria But Does Not Alter Calcium Retention or Cytochrome C Release
Kranthi Kumari Naga et al.
NEUROMOLECULAR MEDICINE (2011)
LATREPIRDINE INCREASES CEREBRAL GLUCOSE UTILIZATION IN AGED MICE AS MEASURED BY [18F]-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY
M. Day et al.
NEUROSCIENCE (2011)
Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice
Julie Vignisse et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease
Karl Kieburtz et al.
ARCHIVES OF NEUROLOGY (2010)
Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles
Alexandre V. Ivachtchenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery of a Proneurogenic, Neuroprotective Chemical
Andrew A. Pieper et al.
CELL (2010)
From Anti-allergic to Anti-Alzheimer's: Molecular Pharmacology of Dimebon™
I. Okun et al.
CURRENT ALZHEIMER RESEARCH (2010)
Functional Genomics of Brain Aging and Alzheimers Disease: Focus on Selective Neuronal Vulnerability
Xinkun Wang et al.
CURRENT GENOMICS (2010)
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
T. Herraiz et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
Marco Giorgetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Mechanism matters
[Anonymous]
NATURE MEDICINE (2010)
Learning from failure
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2010)
Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities
Herve Schaffhauser et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds
S. O. Bachurin et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2009)
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
Nora Goeckler et al.
FEBS JOURNAL (2009)
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models
Makiko Yamashita et al.
FEBS LETTERS (2009)
A beta aggregation and possible implications in Alzheimer's disease pathogenesis
Prashant R. Bharadwaj et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations
Davide Tampellini et al.
JOURNAL OF NEUROSCIENCE (2009)
Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
John W. Steele et al.
MOLECULAR NEURODEGENERATION (2009)
Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells
Yoo Jung Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Polyphenols as potential inhibitors of amyloid aggregation and toxicity: Possible significance to Alzheimer's disease
S. Bastianetto et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Dimebon in Alzheimer's disease: old drug for new indication
Alistair Burns et al.
LANCET (2008)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
Evaluation of Dimebon in cellular model of Huntington's disease
Jun Wu et al.
MOLECULAR NEURODEGENERATION (2008)
Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
John R. Cirrito et al.
NEURON (2008)
Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials
Roberto Raschetti et al.
PLOS MEDICINE (2007)
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
Warren D. Hirst et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model
JoAnne McLaurin et al.
NATURE MEDICINE (2006)
Clinical trials in mild cognitive impairment: lessons for the future
V Jelic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: A multicenter double-blind tyial
PT Ninan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Therapeutic targets: Progress of their exploration and investigation of their characteristics
C. J. Zheng et al.
PHARMACOLOGICAL REVIEWS (2006)
Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications
P Bubber et al.
ANNALS OF NEUROLOGY (2005)
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease - FDG-PET studies in MCI and AD
L Mosconi
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Neuron specific alpha-adrenergic receptor expression in human cerebellum: Implications for emerging cerebellar roles in neurologic disease
UB Schambra et al.
NEUROSCIENCE (2005)
Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
SM Cardoso et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
VV Grigor'ev et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Role of 5-HT6 receptors in memory formation
A Meneses
DRUG NEWS & PERSPECTIVES (2001)
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
MA Chishti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The physiology of brain histamine
RE Brown et al.
PROGRESS IN NEUROBIOLOGY (2001)
Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease
J Thome et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Cell biology - Autophagy as a regulated pathway of cellular degradation
DJ Klionsky et al.
SCIENCE (2000)
Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
RA Glennon et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Dimebon improves learning in animals with experimental Alzheimer's disease
NN Lermontova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
Low affinity use-dependent NMDA receptor antagonists show promise for clinical development
GC Palmer et al.
AMINO ACIDS (2000)
Share Paper
